GlycoMimetics rumored to have postponed IPO

GlycoMimetics Inc. (Gaithersburg, Md.) declined to comment on media reports that the biotech postponed its IPO. In late October, GlycoMimetics amended the offering and said it planned to sell 4 million shares at $14-$16. At the $15 midpoint, the company would have raised $85 million and been valued at $413.9 million. GlycoMimetics first filed to raise up to $86.3 million in the IPO in early October. Jefferies; Barclays Capital; Stifel, Nicolaus; and Canaccord were underwriters. Jefferies declined to comment, while the other banks could not be reached. ...